Immediate Impact

59 standout
Sub-graph 1 of 23

Citing Papers

Antibody–Drug Conjugates (ADCs): current and future biopharmaceuticals
2025 Standout
Effective extracellular payload release and immunomodulatory interactions govern the therapeutic effect of trastuzumab deruxtecan (T-DXd)
2025 Standout
1 intermediate paper

Works of Dennis John Kuo being referenced

Treatment of Recurrent Refractory Pediatric Pre-B Acute Lymphoblastic Leukemia Using Inotuzumab Ozogamicin Monotherapy Resulting in CD22 Antigen Expression Loss as a Mechanism of Therapy Resistance
2019

Author Peers

Author Last Decade Papers Cites
Dennis John Kuo 56 51 74 104 87 50 362
Grażyna Sobol 75 64 65 87 49 40 366
Monika Pogorzała 71 38 53 134 66 31 333
Dorothy J. Ganick 63 73 71 104 95 28 387
Angélique Rome 37 56 129 87 61 34 410
John Fort 22 43 41 84 87 25 335
Shui Yen Soh 26 31 67 67 51 49 347
Shripad Banavali 31 93 72 64 23 48 314
Lale Atahan 68 34 74 103 31 30 398
Luke Maese 93 55 96 56 45 49 341
Hideyuki Koharazawa 31 184 113 51 39 40 395

All Works

Loading papers...

Rankless by CCL
2026